双作用细胞纳米粒子用于有效的 (Pb2+) 排毒
Wei-Ting Shen1, Jiayuan Alex Zhang1, Yiyan Yu1
1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, California 92093, United States.
ACS nano
|October 17, 2025
概括
新的神经元模拟纳米粒子通过中和毒性和氧化应激有效地排毒 (Pb2+). 这种双重作用的方法对治疗中毒有望带来系统性和神经保护性益处.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 毒理学 毒理学 毒理学
背景情况:
- 暴露于 (Pb2+) 是一个重要的公共卫生问题,由于其普遍存在和严重的毒性.
- 现有的中毒治疗方法在有效性和向性治疗方面存在局限性.
研究的目的:
- 开发和评估新的双作用,神经元模拟细胞膜涂层纳米粒子 (CNPs) 进行有效的 (Pb2+) 排毒.
- 在中毒的体外和体外模型中评估这些纳米粒子的治疗潜力.
主要方法:
- 在金属有机框架 (MOF) 内封装DNA体的CNP的配方,覆盖SH-SY5Y细胞膜.
- 在实验室评估Pb2+的结合能力,体稳定性和中和Pb2+诱导的毒性,氧化应激和SH-SY5Y细胞中的脂质过氧化.
- 在中毒的小鼠模型中的治疗功效的体内评估,包括生存率,器官损伤和行为恢复,以及毒性研究.
主要成果:
- 开发的Neuron-MOF/aptamer-NP表现出强大的Pb2+结合,稳定性和对DNA泄漏的抗性.
- 试验室研究表明,Pb2+毒性,氧化应激和脂质过氧化的强烈双作用中和.
- 在体内研究显示,中毒小鼠的生存率提高,器官损伤减少,认知和运动功能恢复,没有观察到急性毒性.
结论:
- 神经元-MOF/体-NP代表了针对排毒的强大和生物相容的治疗平台.
- 开发的纳米粒子为治疗中毒提供了显著的系统性和神经保护性益处.
- 这种方法有望推进针对重金属毒性的治疗策略.
相关概念视频
Enhanced Elimination of Poison
859
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
859
Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K


